Vasculitis Panel

Vasculitis encompasses a range of disorders characterized by inflammation of blood vessels, which can cause significant damage to various organs and tissues throughout the body. The inflammation caused by vasculitis can result in symptoms ranging from mild, such as fever and fatigue, to severe, including organ dysfunction and life-threatening complications. Given the diverse nature and potential severity of vasculitis, accurate diagnosis and effective management are critical for improving patient outcomes.

The Vasculitis Panel is crucial for diagnosing, managing, and monitoring vasculitis through a series of specialized blood tests that identify specific autoantibodies and biomarkers linked to various types of vasculitis. This profile includes tests for PR3 (Proteinase 3), MPO (myeloperoxidase anti-neutrophil cytoplasmic antibodies), and GBM (glomerular basement membrane antibodies). PR3 and MPO are key in diagnosing ANCA-associated vasculitides (AAV), such as granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and microscopic polyangiitis, with elevated levels indicating these conditions, guiding  treatment decisions and monitoring disease progression. On the other hand, GBM antibodies are associated with Goodpasture syndrome, which affects the kidneys and lungs. Detecting GBM antibodies helps confirm this diagnosis and helps formulate treatment strategies. Effective management may involve immunosuppressive therapies and regular monitoring to assess treatment response and disease progression.

No special preparation is required for this panel. However, it is crucial to inform your doctor about any medications or supplements you are taking, as they might affect test results. 

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation, therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results.